No Data
No Data
Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research
Rapid Dose Therapeutics to Showcase Xylistrip, a Dental Product, at Key Tradeshows Across Canada
Rapid Dose Therapeutics Advances Collaboration With Global Leader for Market-Ready QuickStrip(R) Nicotine in 2025
Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees
Rapid Dose Announces Proposed Equity Private Placement Financing and Proposed Shares for Debt Settlement
Rapid Dose Therapeutics Corp. Files Patent Application for Lidocaine Oral Thin Strip